Product Information
FONDAPARINUX 5 MG/0.4 ML SYR is a generic product labeled by Mylan Institutional LLC, priced at $55.3125 per ML under NDC 67457058304. Its NADAC has been published 66 times since May 21, 2025.
FDA first approved this application on Dec 7, 2001. Its Orange Book therapeutic-equivalence code is AP.
Strength
5 mg/.4mL
Manufacturer
Mylan Institutional LLCNDC
67457058304
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/17/2025
Active Ingredients
FONDAPARINUX SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA021345FDA Approved
12/7/2001
TE Code
AP
On Market Since
1/5/2015
Pharmacological Classes
Price Statistics
The NADAC for FONDAPARINUX 5 MG/0.4 ML SYR has been published 66 times since May 21, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $55.3125 per ML |
|---|---|
| All-time high | $55.3125 (Aug 19, 2026) |
| All-time low | $55.3125 (May 21, 2025) |
| 52-week high | $55.3125 |
| 52-week low | $55.3125 |
| Median price | $55.3125 |
| Average price | $55.3125 |
| Largest weekly change | 0.0% (May 28, 2025) |
| Weeks tracked | 66 |
| Tracking since | May 21, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FONDAPARINUX 5 MG/0.4 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 5 MG/0.4 ML SYR, manufactured by Mylan Institutional LLC, is $55.3125 per ML (NDC 67457058304), effective Aug 19, 2026.
How has the price of FONDAPARINUX 5 MG/0.4 ML SYR changed over time?
Over the history we have for it, the NADAC for FONDAPARINUX 5 MG/0.4 ML SYR has held within roughly two percent of its current level. It has been tracked across 66 weekly CMS publications since May 21, 2025.
What are the highest and lowest recorded NADAC prices for FONDAPARINUX 5 MG/0.4 ML SYR?
Since May 21, 2025, the NADAC for FONDAPARINUX 5 MG/0.4 ML SYR has ranged from a low of $55.3125 (May 21, 2025) to a high of $55.3125 (Aug 19, 2026), with a median of $55.3125 per ML.
Are there cheaper alternatives to FONDAPARINUX 5 MG/0.4 ML SYR?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FONDAPARINUX 5 MG/0.4 ML SYR in a comparable dosage form, but none are currently priced below it.
Who manufactures FONDAPARINUX 5 MG/0.4 ML SYR?
FONDAPARINUX 5 MG/0.4 ML SYR (NDC 67457058304) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.